Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
All-Trans Retinoic Acid-Induced Focal Myositis, Synovitis, and Mononeuritis
Journal of Clinical Rheumatology (JCR), 10/14/09
Yu W et al. – Here the authors report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, synovitis, and possible vasculitis, after receiving all–trans retinoic acid therapy. The authors review the existing literature on this rare clinical entity, all–trans retinoic acid–induced myositis. This condition can manifest as fever, myalgia, arthralgia, and Sweet syndrome, accompanied by distinct magnetic resonance findings involving the lower extremity musculature. Treatment consists of discontinuation of the offending drug and often high dose corticosteroids.
Related Articles
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
Haematologica, 11/16/09
Relevance Score: 78%
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia - triggering the differentiation syndrome
Blood, 11/02/09
Relevance Score: 78%
Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid
Journal of Pharmacy and Pharmacology, 10/15/09
Relevance Score: 78%
Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting
BMC Cancer, 11/02/09
Relevance Score: 77%
Activation of retinoic acid receptors by dihydroretinoids
Molecular Pharmacology, 10/08/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


